Nebcin and Fever - a phase IV clinical study of FDA data

Summary:

Fever is reported as a side effect among people who take Nebcin (tobramycin sulfate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Creon, and have Constipation.

The phase IV clinical study analyzes which people have Fever when taking Nebcin. It is created by eHealthMe based on reports of 217 people who have side effects when taking Nebcin from the FDA, and is updated regularly.

What is Nebcin?

Nebcin has active ingredients of tobramycin sulfate. eHealthMe is studying from 217 Nebcin users. Check the latest studies of Nebcin.

What is Fever?

Fever is found to be associated with 3,495 drugs and 6,198 conditions by eHealthMe. Check the latest studies of Fever.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

217 people reported to have side effects when taking Nebcin.
Among them, 25 people (11.52%) have Fever.

Among these 25 people:

How long have people been on Nebcin when they have Fever? *

What is the gender of people who have Fever when taking Nebcin? *

female: 32 %
male: 68 %

What is the age of people who have Fever when taking Nebcin? *

What are other drugs people take besides Nebcin? *

What are other side effects people have besides Fever? *

Headache (pain in head): 10 people, 40.00%
Dyspnea (difficult or laboured breathing): 9 people, 36.00%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 9 people, 36.00%
Cough: 9 people, 36.00%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 9 people, 36.00%
Sputum Increased: 9 people, 36.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 36.00%
Diarrhea: 9 people, 36.00%
Weight Increased: 6 people, 24.00%
Secretion Discharge: 6 people, 24.00%

What are the existing conditions these people have? *

Cough: 10 people, 40.00%
Rickets (softening of bones): 10 people, 40.00%
Constipation: 10 people, 40.00%
Cystic Fibrosis (disease of the secretary glands): 9 people, 36.00%
Nausea (feeling of having an urge to vomit): 9 people, 36.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 36.00%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 9 people, 36.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 36.00%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 8 people, 32.00%
Sedation: 8 people, 32.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nebcin and have Fever?

- Check whether Fever is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nebcin:

Nebcin (217 reports)

Fever treatments and more:

Fever (498,666 reports)

Browse all side effects of Nebcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fever:

Fever (3,495 drugs)

Browse all the conditions that are associated with Fever:

Fever (6,198 conditions)

Related publications that referenced our studies

Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .
Schiller D, Maieron A, Sch?fl R, Donnerer J, "Drug fever due to a single dose of pantoprazole", Pharmacology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin sulfate (the active ingredients of Nebcin) and Nebcin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.